ORY Oryzon Genomics SA BME · Spain

Oryzon Genomics SA (ORY) news

Oryzon Genomics SA is a public biotech or pharmaceutical company listed on BME under the ticker ORY, recorded under Spain. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Oryzon Genomics SA news

We have not published a story on Oryzon Genomics SA yet. When there is news, it will appear here.

Questions about Oryzon Genomics SA

What is the ticker symbol of Oryzon Genomics SA?

Oryzon Genomics SA trades under the ticker ORY on BME.

Where is Oryzon Genomics SA listed?

Oryzon Genomics SA is listed on BME. Our directory also records these other listings: GETTEX:ORN; LSE:0RDB; LSX:A2ACV2.

Which country or territory is Oryzon Genomics SA listed under?

Our directory records Oryzon Genomics SA under Spain.

What does Oryzon Genomics SA do?

Our directory classifies Oryzon Genomics SA as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Oryzon Genomics SA?

The ISIN recorded for Oryzon Genomics SA is ES0167733015.

Does aibio.space cover Oryzon Genomics SA?

aibio.space lists Oryzon Genomics SA among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Oryzon Genomics SA?

Companies in our directory listed in the same country and business area as Oryzon Genomics SA: Pharma Mar SA, Labiana Health SA, Laboratorios Farmaceuticos Rovi, Almirall SA, Faes Farma, Biotechnology Assets SA.

Investor discussion: Oryzon Genomics SA

Members talk about Oryzon Genomics SA (ORY). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open BME:ORY on TradingView.

Listing details

Company: Oryzon Genomics SA
Ticker: ORY
Listing: BME
Country or territory: Spain
Business scope: Biopharma / pharmaceutical profile checked
ISIN: ES0167733015
Other listed symbols: GETTEX:ORN; LSE:0RDB; LSX:A2ACV2
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction